Nurix Therapeutics, Inc. (NRIX)

Nurix Therapeutics experienced significant selling activity over the past ninety days, with insiders offloading over 800,000 dollars in net value. Executives, including the CFO and CLO, executed multiple planned divestments amid a 40.9 percent stock decline. These transactions occurred following the most recent results financiers, which showed a substantial earnings beat.
Ticker: NRIX Exchange: NMS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Nurix Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
368.78
Quantity 8,587 +40.6%
Value US$2,888,802
2.9
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
388.45
Quantity 29,506 +45.9%
Value US$2,873,571
2.9
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
116.99
Quantity 80,991
Value US$4,870,980
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
25.83
Quantity 1,000 -58.1%
Value US$100,000
2.9
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
25.70
Quantity 1,000
Value US$100,000
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
26.76
Quantity 1,000 -9.3%
Value US$100,000
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
25.74
Quantity 1,000 -45.1%
Value US$100,000
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
26.80
Quantity 1,000 -1.2%
Value US$100,000
2.9
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
26.80
Quantity 1,000
Value US$100,000
2.9
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
26.28
Quantity 1,000 -5.6%
Value US$100,000
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
26.28
Quantity 1,000 -20.5%
Value US$100,000
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
26.28
Quantity 1,000 -3.1%
Value US$100,000
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
25.00
Quantity 1,452 -1.2%
Value US$36,300
3.2
JULIA GREGORY Director Non-Executive Director
Transaction date
Proposed sale
Price
23.40
Quantity 22,583
Value US$528,528
3.2
GREGORY JULIA P Non-Executive Director
Transaction date
Sale
Price
23.40
Quantity 22,583 -67.7%
Value US$528,528
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
23.19
Quantity 5,786 -38.8%
Value US$134,149
2.9
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
23.34
Quantity 5,786
Value US$135,045
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
26.64
Quantity 400 -4.2%
Value US$10,655
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
25.69
Quantity 5,387 -36.2%
Value US$138,417
2.9
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
26.04
Quantity 5,787
Value US$150,693
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
25.47
Quantity 1,452 -1.2%
Value US$36,982
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
25.00
Quantity 4,356 -3.6%
Value US$108,900
2.9
GWENN HANSEN Officer Officer
Transaction date
Proposed sale
Price
24.69
Quantity 8,712
Value US$215,099
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
24.64
Quantity 2,611 -2.2%
Value US$64,339
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
23.87
Quantity 1,500 -1.2%
Value US$35,803
2.9
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
24.65
Quantity 2,967 -6.9%
Value US$73,129
2.9
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
23.89
Quantity 1,794 -4.0%
Value US$42,861
2.9
GWENN M HANSEN Officer Officer
Transaction date
Proposed sale
Price
23.22
Quantity 4,111
Value US$95,457
2.9
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
23.22
Quantity 4,761
Value US$110,550
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
23.05
Quantity 16,589 -64.6%
Value US$382,358
2.9
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
23.21
Quantity 16,589
Value US$385,031
2.9
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
23.38
Quantity 2,845 -6.0%
Value US$66,524
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
23.38
Quantity 3,847 -16.2%
Value US$89,954
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
23.38
Quantity 3,847 -3.1%
Value US$89,954
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
23.56
Quantity 11,008 -44.8%
Value US$259,366
2.9
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
23.91
Quantity 11,008
Value US$263,201
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 5,394 -4.5%
Value US$107,880
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
20.06
Quantity 28,935 -68.1%
Value US$580,506
2.9
GWENN M HANSEN Officer Officer
Transaction date
Proposed sale
Price
19.30
Quantity 5,394
Value US$104,104
2.9
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
19.30
Quantity 28,935
Value US$558,446
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
16.60
Quantity 8,148 -37.5%
Value US$135,253
2.9
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
17.39
Quantity 8,148
Value US$141,694
2.9
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
17.18
Quantity 582 -1.5%
Value US$9,996
2.9
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
16.58
Quantity 13,473 -26.1%
Value US$223,323
2.9
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
16.93
Quantity 14,055
Value US$237,951
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
16.96
Quantity 8,148 -30.8%
Value US$138,210
2.9
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
16.81
Quantity 8,148
Value US$136,968
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
16.76
Quantity 5,394 -16.9%
Value US$90,407
2.9
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
16.70
Quantity 5,394
Value US$90,080
2.9
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
16.65
Quantity 2,388 -4.4%
Value US$39,749
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
16.65
Quantity 3,214 -2.6%
Value US$53,498
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
16.65
Quantity 3,214 -9.2%
Value US$53,498
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
15.24
Quantity 8,148 -23.5%
Value US$124,149
2.9
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
15.48
Quantity 8,148
Value US$126,131
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
15.44
Quantity 8,148 -19.1%
Value US$125,793
2.9
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
15.97
Quantity 8,148
Value US$130,124
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
16.66
Quantity 14,261 -25.0%
Value US$237,618
2.9
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
16.85
Quantity 14,261
Value US$240,298
2.9
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
17.37
Quantity 73 -0.2%
Value US$1,268
2.9
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
16.58
Quantity 3,588 -7.3%
Value US$59,498
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
17.37
Quantity 98 -0.1%
Value US$1,702
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
16.58
Quantity 4,797 -5.4%
Value US$79,547
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
17.37
Quantity 88 -0.2%
Value US$1,529
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
16.58
Quantity 4,333 -7.1%
Value US$71,852
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
18.42
Quantity 3,760 -6.9%
Value US$69,273
2.9
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
18.21
Quantity 7,520
Value US$136,939
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
18.56
Quantity 200 -0.4%
Value US$3,711
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
17.87
Quantity 3,560 -6.5%
Value US$63,603
2.9
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
16.76
Quantity 37,600
Value US$630,176
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
17.07
Quantity 37,600 -42.5%
Value US$641,697
2.9
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
12.94
Quantity 6,284
Value US$81,315
2.9
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
12.56
Quantity 6,284 -14.3%
Value US$78,931
2.9
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
12.80
Quantity 3,130 -6.7%
Value US$40,054
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
12.80
Quantity 4,087 -5.1%
Value US$52,300
2.9
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
12.80
Quantity 3,644 -6.7%
Value US$46,631
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-04 2026-11-04 PlS Planned sale

Chief Financial Officer

Officer
8,587 +40.6%
368.78
US$2,888,802
8,587 +40.6% 368.78 US$2,888,802
2026-11-04 2026-11-04 PlS Planned sale

Chief Financial Officer

Officer
29,506 +45.9%
388.45
US$2,873,571
29,506 +45.9% 388.45 US$2,873,571
2026-11-04 2026-11-04 PrS Proposed sale

Officer

Officer
80,991
116.99
US$4,870,980
80,991 116.99 US$4,870,980
2026-11-04 2026-11-03 PlS Planned sale

Chief Legal Officer

Officer
1,000 -58.1%
25.83
US$100,000
1,000 -58.1% 25.83 US$100,000
2026-11-03 2026-11-03 PrS Proposed sale

Officer

Officer
1,000
25.70
US$100,000
1,000 25.70 US$100,000
2026-11-04 2026-11-02 PlS Planned sale

Chief Legal Officer

Officer
1,000 -9.3%
26.76
US$100,000
1,000 -9.3% 26.76 US$100,000
2026-11-04 2026-11-02 PlS Planned sale

Chief Legal Officer

Officer
1,000 -45.1%
25.74
US$100,000
1,000 -45.1% 25.74 US$100,000
2026-11-02 2026-11-02 PlS Planned sale

Chief Scientific Officer

Officer
1,000 -1.2%
26.80
US$100,000
1,000 -1.2% 26.80 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale

Officer

Officer
1,000
26.80
US$100,000
1,000 26.80 US$100,000
2026-11-02 2026-10-30 S Sale

Chief Financial Officer

Officer
1,000 -5.6%
26.28
US$100,000
1,000 -5.6% 26.28 US$100,000
2026-11-02 2026-10-30 S Sale

Chief Legal Officer

Officer
1,000 -20.5%
26.28
US$100,000
1,000 -20.5% 26.28 US$100,000
2026-11-02 2026-10-30 S Sale

Chief Scientific Officer

Officer
1,000 -3.1%
26.28
US$100,000
1,000 -3.1% 26.28 US$100,000
2026-10-15 2026-10-15 PlS Planned sale

Chief Scientific Officer

Officer
1,452 -1.2%
25.00
US$36,300
1,452 -1.2% 25.00 US$36,300
2026-10-14 2026-10-14 PrS Proposed sale

Director

Non-Executive Director
22,583
23.40
US$528,528
22,583 23.40 US$528,528
2026-10-14 2026-10-14 S Sale Non-Executive Director
22,583 -67.7%
23.40
US$528,528
22,583 -67.7% 23.40 US$528,528
2026-10-02 2026-10-02 PlS Planned sale

Chief Legal Officer

Officer
5,786 -38.8%
23.19
US$134,149
5,786 -38.8% 23.19 US$134,149
2026-10-02 2026-10-02 PrS Proposed sale

Officer

Officer
5,786
23.34
US$135,045
5,786 23.34 US$135,045
2026-09-02 2026-09-02 PlS Planned sale

Chief Legal Officer

Officer
400 -4.2%
26.64
US$10,655
400 -4.2% 26.64 US$10,655
2026-09-02 2026-09-02 PlS Planned sale

Chief Legal Officer

Officer
5,387 -36.2%
25.69
US$138,417
5,387 -36.2% 25.69 US$138,417
2026-09-02 2026-09-02 PrS Proposed sale

Officer

Officer
5,787
26.04
US$150,693
5,787 26.04 US$150,693
2026-09-01 2026-09-01 PlS Planned sale

Chief Scientific Officer

Officer
1,452 -1.2%
25.47
US$36,982
1,452 -1.2% 25.47 US$36,982
2026-08-05 2026-08-05 PlS Planned sale

Chief Scientific Officer

Officer
4,356 -3.6%
25.00
US$108,900
4,356 -3.6% 25.00 US$108,900
2026-08-05 2026-08-05 PrS Proposed sale

Officer

Officer
8,712
24.69
US$215,099
8,712 24.69 US$215,099
2026-08-05 2026-08-04 PlS Planned sale

Chief Scientific Officer

Officer
2,611 -2.2%
24.64
US$64,339
2,611 -2.2% 24.64 US$64,339
2026-08-05 2026-08-04 PlS Planned sale

Chief Scientific Officer

Officer
1,500 -1.2%
23.87
US$35,803
1,500 -1.2% 23.87 US$35,803
2026-08-04 2026-08-04 PlS Planned sale

Chief Financial Officer

Officer
2,967 -6.9%
24.65
US$73,129
2,967 -6.9% 24.65 US$73,129
2026-08-04 2026-08-04 PlS Planned sale

Chief Financial Officer

Officer
1,794 -4.0%
23.89
US$42,861
1,794 -4.0% 23.89 US$42,861
2026-08-04 2026-08-04 PrS Proposed sale

Officer

Officer
4,111
23.22
US$95,457
4,111 23.22 US$95,457
2026-08-04 2026-08-04 PrS Proposed sale

Officer

Officer
4,761
23.22
US$110,550
4,761 23.22 US$110,550
2026-08-03 2026-08-03 PlS Planned sale

Chief Legal Officer

Officer
16,589 -64.6%
23.05
US$382,358
16,589 -64.6% 23.05 US$382,358
2026-08-03 2026-08-03 PrS Proposed sale

Officer

Officer
16,589
23.21
US$385,031
16,589 23.21 US$385,031
2026-07-30 2026-07-30 S Sale

Chief Financial Officer

Officer
2,845 -6.0%
23.38
US$66,524
2,845 -6.0% 23.38 US$66,524
2026-07-30 2026-07-30 S Sale

Chief Legal Officer

Officer
3,847 -16.2%
23.38
US$89,954
3,847 -16.2% 23.38 US$89,954
2026-07-30 2026-07-30 S Sale

Chief Scientific Officer

Officer
3,847 -3.1%
23.38
US$89,954
3,847 -3.1% 23.38 US$89,954
2026-07-02 2026-07-02 PlS Planned sale

Chief Legal Officer

Officer
11,008 -44.8%
23.56
US$259,366
11,008 -44.8% 23.56 US$259,366
2026-07-02 2026-07-02 PrS Proposed sale

Officer

Officer
11,008
23.91
US$263,201
11,008 23.91 US$263,201
2026-06-25 2026-06-25 PlS Planned sale

Chief Scientific Officer

Officer
5,394 -4.5%
20.00
US$107,880
5,394 -4.5% 20.00 US$107,880
2026-06-25 2026-06-25 PlS Planned sale

Chief Legal Officer

Officer
28,935 -68.1%
20.06
US$580,506
28,935 -68.1% 20.06 US$580,506
2026-06-25 2026-06-25 PrS Proposed sale

Officer

Officer
5,394
19.30
US$104,104
5,394 19.30 US$104,104
2026-06-25 2026-06-25 PrS Proposed sale

Officer

Officer
28,935
19.30
US$558,446
28,935 19.30 US$558,446
2026-06-02 2026-06-02 PlS Planned sale

Chief Legal Officer

Officer
8,148 -37.5%
16.60
US$135,253
8,148 -37.5% 16.60 US$135,253
2026-06-02 2026-06-02 PrS Proposed sale

Officer

Officer
8,148
17.39
US$141,694
8,148 17.39 US$141,694
2026-05-05 2026-05-05 PlS Planned sale

Chief Financial Officer

Officer
582 -1.5%
17.18
US$9,996
582 -1.5% 17.18 US$9,996
2026-05-05 2026-05-05 PlS Planned sale

Chief Financial Officer

Officer
13,473 -26.1%
16.58
US$223,323
13,473 -26.1% 16.58 US$223,323
2026-05-05 2026-05-05 PrS Proposed sale

Officer

Officer
14,055
16.93
US$237,951
14,055 16.93 US$237,951
2026-05-04 2026-05-04 PlS Planned sale

Chief Legal Officer

Officer
8,148 -30.8%
16.96
US$138,210
8,148 -30.8% 16.96 US$138,210
2026-05-04 2026-05-04 PrS Proposed sale

Officer

Officer
8,148
16.81
US$136,968
8,148 16.81 US$136,968
2026-05-01 2026-05-01 PlS Planned sale

Chief Legal Officer

Officer
5,394 -16.9%
16.76
US$90,407
5,394 -16.9% 16.76 US$90,407
2026-05-01 2026-05-01 PrS Proposed sale

Officer

Officer
5,394
16.70
US$90,080
5,394 16.70 US$90,080
2026-04-30 2026-04-30 S Sale

Chief Financial Officer

Officer
2,388 -4.4%
16.65
US$39,749
2,388 -4.4% 16.65 US$39,749
2026-04-30 2026-04-30 S Sale

Chief Scientific Officer

Officer
3,214 -2.6%
16.65
US$53,498
3,214 -2.6% 16.65 US$53,498
2026-04-30 2026-04-30 S Sale

Chief Legal Officer

Officer
3,214 -9.2%
16.65
US$53,498
3,214 -9.2% 16.65 US$53,498
2026-04-02 2026-04-02 PlS Planned sale

Chief Legal Officer

Officer
8,148 -23.5%
15.24
US$124,149
8,148 -23.5% 15.24 US$124,149
2026-04-02 2026-04-02 PrS Proposed sale

Officer

Officer
8,148
15.48
US$126,131
8,148 15.48 US$126,131
2026-03-02 2026-03-02 PlS Planned sale

Chief Legal Officer

Officer
8,148 -19.1%
15.44
US$125,793
8,148 -19.1% 15.44 US$125,793
2026-03-02 2026-03-02 PrS Proposed sale

Officer

Officer
8,148
15.97
US$130,124
8,148 15.97 US$130,124
2026-02-09 2026-02-09 PlS Planned sale

Chief Legal Officer

Officer
14,261 -25.0%
16.66
US$237,618
14,261 -25.0% 16.66 US$237,618
2026-02-09 2026-02-09 PrS Proposed sale

Officer

Officer
14,261
16.85
US$240,298
14,261 16.85 US$240,298
2026-01-30 2026-01-30 S Sale

Chief Financial Officer

Officer
73 -0.2%
17.37
US$1,268
73 -0.2% 17.37 US$1,268
2026-01-30 2026-01-30 S Sale

Chief Financial Officer

Officer
3,588 -7.3%
16.58
US$59,498
3,588 -7.3% 16.58 US$59,498
2026-01-30 2026-01-30 S Sale

Chief Scientific Officer

Officer
98 -0.1%
17.37
US$1,702
98 -0.1% 17.37 US$1,702
2026-01-30 2026-01-30 S Sale

Chief Scientific Officer

Officer
4,797 -5.4%
16.58
US$79,547
4,797 -5.4% 16.58 US$79,547
2026-01-30 2026-01-30 S Sale

Chief Legal Officer

Officer
88 -0.2%
17.37
US$1,529
88 -0.2% 17.37 US$1,529
2026-01-30 2026-01-30 S Sale

Chief Legal Officer

Officer
4,333 -7.1%
16.58
US$71,852
4,333 -7.1% 16.58 US$71,852
2026-01-20 2026-01-20 PlS Planned sale

Chief Legal Officer

Officer
3,760 -6.9%
18.42
US$69,273
3,760 -6.9% 18.42 US$69,273
2025-12-18 2025-12-18 PrS Proposed sale

Officer

Officer
7,520
18.21
US$136,939
7,520 18.21 US$136,939
2025-12-18 2025-12-18 PlS Planned sale

Chief Legal Officer

Officer
200 -0.4%
18.56
US$3,711
200 -0.4% 18.56 US$3,711
2025-12-18 2025-12-18 PlS Planned sale

Chief Legal Officer

Officer
3,560 -6.5%
17.87
US$63,603
3,560 -6.5% 17.87 US$63,603
2025-11-24 2025-11-24 PrS Proposed sale

Officer

Officer
37,600
16.76
US$630,176
37,600 16.76 US$630,176
2025-11-24 2025-11-24 PlS Planned sale

Chief Legal Officer

Officer
37,600 -42.5%
17.07
US$641,697
37,600 -42.5% 17.07 US$641,697
2025-11-03 2025-11-03 PrS Proposed sale

Officer

Officer
6,284
12.94
US$81,315
6,284 12.94 US$81,315
2025-11-03 2025-11-03 PlS Planned sale

Chief Financial Officer

Officer
6,284 -14.3%
12.56
US$78,931
6,284 -14.3% 12.56 US$78,931
2025-10-30 2025-10-30 S Sale

Chief Financial Officer

Officer
3,130 -6.7%
12.80
US$40,054
3,130 -6.7% 12.80 US$40,054
2025-10-30 2025-10-30 S Sale

Chief Scientific Officer

Officer
4,087 -5.1%
12.80
US$52,300
4,087 -5.1% 12.80 US$52,300
2025-10-30 2025-10-30 S Sale

Chief Legal Officer

Officer
3,644 -6.7%
12.80
US$46,631
3,644 -6.7% 12.80 US$46,631

See older Nurix Therapeutics, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Nurix Therapeutics, Inc. history with Plus

Billed monthly · Cancel anytime